Additionally, by decreasing tau phosphorylation, upregulating pre- and postsynaptic protein expression, and repairing cytoskeletal damage, BG45 may have increased synaptic plasticity in cell and animal models of early AD. The gene discussed is MAPT; the disease is Alzheimer disease.